|
PnALT‡ |
PeALT |
p-value§
|
Male, n [%] |
32 [80] |
33 [82.5] |
0.775 |
Age, years |
40.95 ± 10.78 |
40.82 ± 8.90 |
0.955 |
BMI, kg/m2 |
24.44 ± 3.55 |
24.49 ± 3.18 |
0.949 |
CAP, dB/m
|
221.42 ± 41.86 |
220.6 ± 38.80 |
0.927 |
TG, mmol/L |
0.93 [0.65–1.41] |
1.15 [0.7–1.61] |
0.394 |
TC, mmol/L |
4.26 [3.54–4.85] |
4.64 [3.99–5.71] |
0.092 |
Follow-up time, years |
2.26 [1.97–3.44] |
2.42
[1.67–3.48] |
0.634 |
Liver cirrhosis, n (%) |
17 [42.5] |
14 [35] |
0.491 |
HBeAg positive, n [%] |
5 [12.5] |
4 [10] |
0.723 |
ALT, U/L |
21 [14–25.75] |
49.5 [42–64.5] |
0.0001 |
AST, U/L |
20 [19–25] |
31 (25. 25–38) |
0.0001 |
LSM, Kpa
|
8.15 [6.125–14.07] |
7 [5.6–9.22] |
0.172 |
ALB, g/L |
44.6 [42.07–47.2] |
45.6 [44–47.1] |
0.368 |
AFP, ng/mL |
3.29 ± 2.2 |
2.84 ± 1.53 |
0.288 |
GLU, mmol/L |
5.2 [4.88–5.53] |
5.07 [4.89–5.36] |
0.600 |
HDL, mmol/L |
1.04 [0.92–1.28] |
1.08 [0.94–1.29] |
0.507 |
LDL, mmol/L |
2.69 ± 0.78 |
3.09 ± 0.73 |
0.021 |
WBC, 109/L |
5.69 [4.99–6.68] |
5.9
[5.19–5.9] |
0.433 |
NEU, 109/L |
3.29 [2.6–3.81] |
3.32
[2.85–4.4] |
0.433 |
PLT, 109/L |
167.5 [105.2–210.2] |
212
[134–257.2] |
0.011 |